Recent Comments

Comment RSS

Aspirin News and Research RSS Feed - Aspirin News and Research

Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.

POZEN commences enrollment in PA32540 phase 3 study

20. November 2009 09:08
POZEN Inc. announced today the start of enrollment for the phase 3 studies for PA32540. PA32540 is a fixed-dose combination of 325 mg of enteric coated aspirin and 40 mg of immediate release omeprazole, under investigation for use in the secondary prevention of heart attacks and strokes in patients at risk for associated gastric ulcers. [More]

Posted in: Drug Trial News | Medical Condition News

Tags: , ,

VerifyNow System, a rapid platelet function assessment platform, evaluated at AHA's Scientific Sessions

20. November 2009 01:12
Accumetrics, Inc., developer of the VerifyNow System, the first point-of-care method for measuring platelet reactivity, announces that its market-leading VerifyNow P2Y12 Test was one of multiple methods evaluated in the POPular study, which was presented during a Late Breaking Clinical Trials session at the American Heart Association's annual Scientific Sessions. [More]

Posted in: Device / Technology News

Tags: , , , , ,

New Drug Application for ticagrelor submitted to FDA

19. November 2009 02:50
AstraZeneca today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome (ACS). [More]

Posted in: Pharmaceutical News

Tags: , , , , , , , , ,

Key findings from AstraZeneca's phase II studies of ticagrelor

18. November 2009 10:42
AstraZeneca today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation. [More]

Drug therapy offers substantial cost savings than angioplasty

18. November 2009 00:43
Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD. [More]

Tips on how to prevent household members from getting sick during flu season

18. November 2009 00:07
someone at home who has H1N1 (swine) flu, it is important for you to prevent other people in the house from getting sick, according to Gary Kalkut, MD, MPH, Senior Vice-President, Chief Medical Officer of Montefiore Medical Center. [More]

Posted in: Disease/Infection News

Tags: , , , , , , , ,

New, reversible antiplatelet drug not superior than irreversible one in patients undergoing PCI

17. November 2009 04:22
A new, reversible antiplatelet drug did not demonstrate superiority over a current irreversible one in reducing the composite of death, heart attack or ischemia-related revascularization in the 48 hours after angioplasty, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009. [More]

Posted in: Medical Procedure News | Medical Condition News | Pharmaceutical News

Tags: , , , ,

Statin therapy should still be used first to reach blood cholesterol levels before considering niacin

17. November 2009 01:03
Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing. Cardiovascular atherosclerosis, as it is also known, is believed responsible for one in three deaths in the United States each year. [More]

Migraine headaches linked with increased risk of common kind of stroke

16. November 2009 11:16
Pooling results from 21 studies, involving 622,381 men and women, researchers at Johns Hopkins have affirmed that migraine headaches are associated with more than twofold higher chances of the most common kind of stroke: those occurring when blood supply to the brain is suddenly cut off by the buildup of plaque or a blood clot. [More]

Posted in: Medical Condition News

Tags: , , , , , , , , ,

Platelet function tests predict heart attacks in patients pre-treated with two anti-clotting medications before coronary stenting

16. November 2009 08:35
Three platelet function tests all identified heart patients who will have blood cells that remain sticky, increasing heart attack risk, despite being pre-treated with two anti-clotting medications before coronary stenting, researchers reported at the American Heart Association's Scientific Sessions 2009. [More]

Posted in: Device / Technology News | Medical Condition News

Tags: , , , , , , ,

Aspirin doses have beneficial effects for patients with heart diorders: Study

16. November 2009 05:36
On Sunday, November 15, 2009, Florida Atlantic University (FAU) researcher Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science will present at the American Heart Association's Annual Scientific Sessions meeting in Orlando, FL, the first data in humans to show that all doses of aspirin used in clinical practice increase nitric oxide. [More]

Posted in: Drug Trial News | Medical Condition News

Tags: , , , , , , ,

New reversible oral anti-platelet medication had fewer cardiac events in heart attack patients

16. November 2009 04:15
Acutely ill heart attack patients who received both aspirin and a new reversible oral anti-platelet medication had fewer cardiac events than patients on aspirin and the most commonly used, irreversible anti-platelet drug, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009. [More]

Posted in: Medical Condition News | Pharmaceutical News

Tags: , , , , , , ,

NQF releases the QDS framework for defining data necessary to measure performance in patient care

13. November 2009 04:23
The National Quality Forum (NQF) announced today the release of the Quality Data Set (QDS), a common technological framework for defining clinical data necessary to measure performance and accelerate improvement in patients' quality of care. The QDS framework provides a standardized set of data that should be captured in patients' electronic health records and is applicable to all care settings a patient is likely to use in his or her lifetime. [More]

Posted in: Device / Technology News | Healthcare News

Tags: , ,

Vanderbilt University researchers study role of statins in reducing flu-related deaths

13. November 2009 04:02
Vanderbilt University Medical Center researchers are studying statins, the class of drugs long associated with lowering cholesterol, as a way to reduce H1N1-related deaths. [More]

"No Drugs Down the Drain" outreach campaign in Sacramento

6. November 2009 05:05
California American Water has designated the week of November 9, 2009 as "No Drugs Down the Drain" week for its Sacramento service area as part of a national campaign sponsored by public and private agencies alike toward the common mission of reducing pharmaceutical pollution in our source water supplies. [More]

Posted in: Pharmaceutical News

Tags: ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.